vs
New Fortress Energy Inc.（NFE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
New Fortress Energy Inc.的季度营收约是REPLIGEN CORP的1.6倍（$326.2M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -259.7%，领先266.4%），REPLIGEN CORP同比增速更快（13.6% vs -7.0%），REPLIGEN CORP自由现金流更多（$17.6M vs $-134.8M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -26.8%）
New Fortress Energy Inc.是一家全球能源基础设施企业，主要开发、持有并运营液化天然气进出口终端、天然气供应网络及低碳能源项目，服务美洲、加勒比地区客户，致力于提供低成本、低排放的能源解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NFE vs RGEN — 直观对比
营收规模更大
NFE
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出20.6%
-7.0%
净利率更高
RGEN
高出266.4%
-259.7%
自由现金流更多
RGEN
多$152.3M
$-134.8M
两年增速更快
RGEN
近两年复合增速
-26.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.2M | $197.9M |
| 净利润 | $-847.1M | $13.3M |
| 毛利率 | 35.5% | 52.5% |
| 营业利润率 | -193.0% | 9.0% |
| 净利率 | -259.7% | 6.7% |
| 营收同比 | -7.0% | 13.6% |
| 净利润同比 | -277.4% | 143.9% |
| 每股收益（稀释后） | $-3.03 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NFERGEN
| Q4 25 | $326.2M | $197.9M | ||
| Q3 25 | $240.3M | $188.8M | ||
| Q2 25 | $228.1M | $182.4M | ||
| Q1 25 | $384.9M | $169.2M | ||
| Q4 24 | $350.7M | $174.1M | ||
| Q3 24 | $446.0M | $154.9M | ||
| Q2 24 | $291.2M | $154.1M | ||
| Q1 24 | $609.5M | $151.3M |
净利润NFERGEN
| Q4 25 | $-847.1M | $13.3M | ||
| Q3 25 | $-263.0M | $14.9M | ||
| Q2 25 | $-546.5M | $14.9M | ||
| Q1 25 | $-175.4M | $5.8M | ||
| Q4 24 | $-224.4M | $-30.3M | ||
| Q3 24 | $9.3M | $-654.0K | ||
| Q2 24 | $-88.9M | $3.3M | ||
| Q1 24 | $54.1M | $2.1M |
毛利率NFERGEN
| Q4 25 | 35.5% | 52.5% | ||
| Q3 25 | 18.1% | 53.2% | ||
| Q2 25 | 8.4% | 50.0% | ||
| Q1 25 | 21.4% | 53.6% | ||
| Q4 24 | 17.6% | 26.1% | ||
| Q3 24 | 27.1% | 50.0% | ||
| Q2 24 | 23.8% | 49.8% | ||
| Q1 24 | 62.4% | 49.5% |
营业利润率NFERGEN
| Q4 25 | -193.0% | 9.0% | ||
| Q3 25 | -37.4% | 8.9% | ||
| Q2 25 | -170.3% | 7.6% | ||
| Q1 25 | -3.3% | 3.9% | ||
| Q4 24 | 65.0% | -17.7% | ||
| Q3 24 | 17.8% | -5.1% | ||
| Q2 24 | 12.3% | 1.0% | ||
| Q1 24 | 30.4% | 1.3% |
净利率NFERGEN
| Q4 25 | -259.7% | 6.7% | ||
| Q3 25 | -109.4% | 7.9% | ||
| Q2 25 | -239.6% | 8.2% | ||
| Q1 25 | -45.6% | 3.4% | ||
| Q4 24 | -64.0% | -17.4% | ||
| Q3 24 | 2.1% | -0.4% | ||
| Q2 24 | -30.5% | 2.2% | ||
| Q1 24 | 8.9% | 1.4% |
每股收益（稀释后）NFERGEN
| Q4 25 | $-3.03 | $0.24 | ||
| Q3 25 | $-0.96 | $0.26 | ||
| Q2 25 | $-1.99 | $0.26 | ||
| Q1 25 | $-0.65 | $0.10 | ||
| Q4 24 | $-1.10 | $-0.55 | ||
| Q3 24 | $0.03 | $-0.01 | ||
| Q2 24 | $-0.42 | $0.06 | ||
| Q1 24 | $0.23 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $226.5M | $767.6M |
| 总债务越低越好 | $8.2B | $542.2M |
| 股东权益账面价值 | $182.6M | $2.1B |
| 总资产 | $10.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 44.78× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NFERGEN
| Q4 25 | $226.5M | $767.6M | ||
| Q3 25 | $145.2M | $748.7M | ||
| Q2 25 | $551.1M | $708.9M | ||
| Q1 25 | $447.9M | $697.2M | ||
| Q4 24 | $492.9M | $757.4M | ||
| Q3 24 | $90.8M | $784.0M | ||
| Q2 24 | $133.0M | $809.1M | ||
| Q1 24 | $143.5M | $780.6M |
总债务NFERGEN
| Q4 25 | $8.2B | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.9B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NFERGEN
| Q4 25 | $182.6M | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.9B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.0B | ||
| Q1 24 | $1.7B | $2.0B |
总资产NFERGEN
| Q4 25 | $10.6B | $2.9B | ||
| Q3 25 | $12.0B | $2.9B | ||
| Q2 25 | $12.0B | $2.9B | ||
| Q1 25 | $13.1B | $2.9B | ||
| Q4 24 | $12.9B | $2.8B | ||
| Q3 24 | $12.0B | $2.8B | ||
| Q2 24 | $11.4B | $2.9B | ||
| Q1 24 | $10.9B | $2.8B |
负债/权益比NFERGEN
| Q4 25 | 44.78× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.74× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-76.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-134.8M | $17.6M |
| 自由现金流率自由现金流/营收 | -41.3% | 8.9% |
| 资本支出强度资本支出/营收 | 18.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-1.4B | $93.9M |
8季度趋势，按日历期对齐
经营现金流NFERGEN
| Q4 25 | $-76.2M | $25.7M | ||
| Q3 25 | $-171.0M | $48.1M | ||
| Q2 25 | $-329.0M | $28.6M | ||
| Q1 25 | $-7.2M | $15.0M | ||
| Q4 24 | $445.3M | $39.2M | ||
| Q3 24 | $-20.0M | $49.3M | ||
| Q2 24 | $113.9M | $42.2M | ||
| Q1 24 | $63.0M | $44.7M |
自由现金流NFERGEN
| Q4 25 | $-134.8M | $17.6M | ||
| Q3 25 | $-231.6M | $43.4M | ||
| Q2 25 | $-726.7M | $21.5M | ||
| Q1 25 | $-262.3M | $11.4M | ||
| Q4 24 | $-210.3M | $33.6M | ||
| Q3 24 | $-367.0M | $42.3M | ||
| Q2 24 | $-493.2M | $37.4M | ||
| Q1 24 | $-457.9M | $36.4M |
自由现金流率NFERGEN
| Q4 25 | -41.3% | 8.9% | ||
| Q3 25 | -96.4% | 23.0% | ||
| Q2 25 | -318.6% | 11.8% | ||
| Q1 25 | -68.2% | 6.8% | ||
| Q4 24 | -60.0% | 19.3% | ||
| Q3 24 | -82.3% | 27.3% | ||
| Q2 24 | -169.3% | 24.3% | ||
| Q1 24 | -75.1% | 24.0% |
资本支出强度NFERGEN
| Q4 25 | 18.0% | 4.1% | ||
| Q3 25 | 25.2% | 2.5% | ||
| Q2 25 | 174.4% | 3.9% | ||
| Q1 25 | 66.3% | 2.1% | ||
| Q4 24 | 187.0% | 3.2% | ||
| Q3 24 | 77.8% | 4.5% | ||
| Q2 24 | 208.4% | 3.1% | ||
| Q1 24 | 85.5% | 5.5% |
现金转化率NFERGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.15× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 1.16× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
